Medically reviewed by Sanja Jelic, MD Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory (lung) ...

Early diagnosis of COPD, chronic obstructive pulmonary disease, increases the quality of life of the patient and the efficacy ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...

Long-term inhaled corticosteroid (ICS) use for chronic obstructive pulmonary disease/ COPD (lung disease) may increase the ...

The following is a summary of “Point-of-care testing reduces antibiotic prescribing in acute exacerbations of chronic ...

for the treatment of chronic obstructive pulmonary disease (COPD) in adults whose disease is not adequately controlled with existing therapy. In addition to COPD, Dupixent is approved in Japan in ...

For patients with chronic obstructive pulmonary disorder (COPD), long-term inhaled corticosteroid (ICS) treatment is ...

In the United States, more than 16 million people have been diagnosed with Chronic Obstructive Pulmonary Disease or COPD, and ...

Adults with arthritis and chronic obstructive pulmonary disease (COPD) have a higher risk for mortality than individuals without COPD.

The systemic immune response index outperformed other inflammatory markers in predicting chronic obstructive pulmonary ...